(Q40432669)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15812531%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Is there a role for minimal residual disease levels in the treatment of ALL patients who receive allogeneic stem cells? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15812531%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15812531%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

M W Schilham

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15812531%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

P Bader

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15812531%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

PD-WP of the EBMT

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15812531%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

English

0 references

publication date

1 March 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15812531%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15812531%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

35 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15812531%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

S49-52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15812531%20AND%20SRC:MED&resulttype=core&format=json

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704847

Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704847

Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704847

Minor histocompatibility antigens: allo target molecules for tumor-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704847

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704847

Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704847

7 January 2021

Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704847

7 January 2021

T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704847

7 January 2021

Minimal residula disease status as a predictor of relapse after allogenic bone marrow transplantation for children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704847

7 January 2021

Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704847

7 January 2021

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704847

7 January 2021

Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704847

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704847

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15812531%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

10 January 2020

1037880217

0 references

Fatcat ID

release_qf3fuxj6nrdwfkxzhli7zf6mlu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qf3fuxj6nrdwfkxzhli7zf6mlu

24 November 2022

mapped directly with Wikidata item

1 reference